Dolby Laboratories (NYSE:DLB) Updates Q1 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.960-1.110 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $307.9 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Analysts Set New Price Targets

DLB has been the topic of a number of research reports. Barrington Research reiterated an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, September 20th. StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday. Finally, Rosenblatt Securities upped their price target on shares of Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a research note on Wednesday.

Check Out Our Latest Report on Dolby Laboratories

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $70.93 on Wednesday. The company has a market cap of $6.76 billion, a price-to-earnings ratio of 32.39 and a beta of 0.98. The firm has a 50 day simple moving average of $73.69 and a 200 day simple moving average of $76.01. Dolby Laboratories has a one year low of $66.35 and a one year high of $90.06.

Dolby Laboratories declared that its Board of Directors has authorized a share repurchase program on Wednesday, August 7th that permits the company to buyback $350.00 million in shares. This buyback authorization permits the electronics maker to buy up to 5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Insider Transactions at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total value of $2,113,309.44. Following the completion of the sale, the chief executive officer now directly owns 83,721 shares in the company, valued at $6,205,400.52. This trade represents a 25.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 39.54% of the company’s stock.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Articles

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.